Diffuse large B-cell lymphoma trials, also abroad
347 open Diffuse large B-cell lymphoma trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.
| Country | Open trials |
|---|---|
| China | 133 |
| United States | 131 |
| Italy | 35 |
| France | 27 |
| Spain | 25 |
| All other countries |
The same trial often runs in several countries
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003) has 1 site in New Zealand and runs in 26 countries. If a site near you is full, another one may still take people.
See A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003) in all 26 countries